Tatva Chintan Listing: Tatva Chintan lists at 95% premium ov

Tatva Chintan Listing: Tatva Chintan lists at 95% premium over issue price


At the issue price, the Tatva Chintan commanded a PE of 41.62 times and a market-cap of Rs 2,400 crore compared with listed peers Aarti Industries' 63 times and Navin Fluorine International at 61.4 times.
Astha Jain of Hem Securities advised long-term investors to pare at least 50 per cent of their holdings. "Investors, who were seeking listing gains only, should book 100 per cent profits on Day 1 itself," she said.
The Rs 500 crore IPO, which was sold from July 16 to 20, saw strong demand. Overall, the issue was subscribed over 180 times, with the quota reserved for qualified institutional buyers (QIBs) 185.23 times while the one reserved for non-institutional investors (NIIs) 512.22 times. The retail quota was subscribed 35.35 times.

Related Keywords

Tatva Chintan Pharma , Aarti Industries , Tatva Chintan , Astha Jain , Navin Fluorine International , Tatva Chintan Pharma Chem , Clean Science , Hem Securities , Chintan Pharma Chem , தத்வா சிந்தன் பார்மா , ஆர்த்தி தொழில்கள் , தத்வா சிந்தன் , ஆஸ்தா ஜெயின் , நவீன் ஃப்ளோரின் சர்வதேச , தத்வா சிந்தன் பார்மா செம் , சுத்தமான அறிவியல் , ஹேம் பத்திரங்கள் , சிந்தன் பார்மா செம் ,

© 2025 Vimarsana